14-Oct-2026 16:32:10
JUBLPHARMAGeneral news
JUBLPHARMA : ICRA ASSIGNS AA+ (STABLE) RATING TO RS 1,400 CR PROPOSED NCD PROGRAMME
Icra assigned [ICRA]AA+ (Stable) rating to the company's proposed non-convertible debentures of ₹1,400 Cr, per its letter dated October 13, 2026.
Jubilant Pharmova Ltd
Open attachment